Tamboran Resources Corp is engaged in the development of Australian oil and natural gas reserves. The company is an early-stage, growth-driven independent natural gas exploration and production company focused on an integrated approach to the commercial development of the natural gas resources in the Beetaloo Basin located within the Northern Territory of Australia. It operates in a single segment with operations in Australia and Rest of the World.
Last trade$26.30
Day change-$0.81 (-2.99%)
Day range$26.13 – $27.95
Volume123,369
Market cap$948M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$947.77M
Price / earnings
—
Price / book
1.18×
Price / sales
—
EV / sales
—
EV / EBITDA
-25.34×
Profitability
Earnings per share
-$0.86
Return on assets
-2.5%
Return on equity
-3.75%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.12×
Current ratio
2.03×
Quick ratio
2.03×
Cash ratio
1.7×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$237.43M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for TBN, quarterly periods
Line item
Q1 FY2027 Sep 30, 2026
Q4 FY2026 Jun 30, 2026
Q3 FY2026 Mar 31, 2026
Q2 FY2026 Dec 31, 2025
Q1 FY2026 Sep 30, 2025
Q4 FY2025 Jun 30, 2025
Q3 FY2025 Mar 31, 2025
Q2 FY2025 Dec 31, 2024
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$0
$0
$0
$0
$0
$0
$0
$0
Selling, general and administrative
$9.98M
$7.38M
$6.72M
$5.92M
$5.41M
$7M
$5.32M
$4.09M
Research and development
$8K
-$234K
$31K
$136K
$191K
$824K
$1.98M
$3.23M
Total operating expenses
$11.86M
$8.29M
$8.37M
$7.8M
$8.21M
$8.52M
$8.8M
$15.02M
Operating income
-$11.86M
-$8.29M
-$8.37M
-$7.8M
-$8.21M
-$8.52M
-$8.8M
-$15.02M
Interest expense
$1.43M
-$591K
$658K
$0
-$305K
-$1.55M
$51K
$0
Income before taxes
-$12.53M
-$3.26M
-$10.62M
-$7.56M
-$9.06M
-$9.2M
-$8.17M
-$15.5M
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
-$12.53M
-$3.26M
-$10.62M
-$7.56M
-$9.06M
-$9.2M
-$8.17M
-$15.5M
Net income attributable to common shareholders
-$12.12M
-$1.87M
-$9.41M
-$6.61M
-$8.18M
-$10.18M
-$6.66M
-$14.17M
EBITDA
-$11.04M
-$7.95M
-$8.04M
-$7.8M
-$7.92M
-$7.88M
-$8.5M
-$14.99M
Basic earnings per share
-$0.35
-$0.06
-$0.42
-$0.33
-$0.47
-$0.65
-$0.46
-$0.99
Diluted earnings per share
-$0.35
-$0.06
-$0.42
-$0.33
-$0.47
-$0.65
-$0.46
-$0.99
Recent news
Company coverage with links to the original publishers.
Falcon Oil & Gas announced that its Shenandoah SS2-1H well achieved an average 20-day initial production flow rate of 10.3 MMcf/d, with normalized rates of 11.9 MMcf/d per 10,000 feet, comparing favorably to Marcellus Shale performance. The company has reduced its participating interest in the well to 0% with no cost exposure. Three additional wells are planned for stimulation in Q2 2026 with production expected in Q3 2026.
Falcon Oil & Gas announced that its transaction with Tamboran Resources was approved by shareholders on March 11, 2026. However, the deal faces uncertainty as a court hearing scheduled for March 13 was adjourned to March 24 due to opposition from shareholder Lamesa Holding S.A. The transaction remains subject to multiple conditions including court approval and NYSE listing authorization. If not completed by March 30, 2026, either party may terminate the agreement.
Falcon Oil & Gas shareholders approved a transaction with Tamboran Resources Corporation with 99.76% of votes cast in favor on March 11, 2026. The transaction remains subject to court approval, NYSE listing authorization, and other standard closing conditions, with expected completion around March 16, 2026. Upon completion, Falcon's shares will be suspended from AIM trading.
Investor rights law firm Halper Sadeh LLC is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting competing offers.
Monteverde & Associates PC is investigating four merger and acquisition transactions involving RAPT Therapeutics, Amicus Therapeutics, Tamboran Resources, and Contango Ore. The firm is encouraging shareholders to act before upcoming votes and tender offer deadlines in March 2026, citing concerns about the proposed deals.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.